Dongbao Bio-Tech(SZ:300239) Xin Lang Cai Jing·2026-01-21 07:17Group 1 - Dongbao Biological experienced a stock price increase of 5.06%, reaching 6.44 CNY per share, with a trading volume of 142 million CNY and a turnover rate of 3.83%, resulting in a total market capitalization of 3.823 billion CNY [1] - The company, Baotou Dongbao Biological Technology Co., Ltd., is located in Baotou City, Inner Mongolia, and was established on March 12, 1997, with its listing date on July 6, 2011. Its main business involves the research, production, and sales of gelatin series products and low molecular weight collagen [1] - The revenue composition of Dongbao Biological includes capsule business at 54.13%, gelatin series products and by-products at 37.30%, collagen business at 7.81%, organic fertilizer business at 0.53%, and other supplementary products at 0.22% [1] Group 2 - Among the top circulating shareholders of Dongbao Biological, one fund from GF Fund Management, the GF Jufeng Mixed A (270005), entered the top ten shareholders in the third quarter, holding 4.5228 million shares, which is 0.77% of the circulating shares. The estimated floating profit today is approximately 1.4021 million CNY [2] - The GF Jufeng Mixed A fund was established on December 23, 2005, with a current scale of 3.366 billion CNY. Year-to-date returns are 11.92%, ranking 540 out of 8844 in its category; the one-year return is 70.13%, ranking 640 out of 8091; and since inception, the return is 556.36% [2]